Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury. These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication.
Bristol-Myers Squibb
275 followers
Astellas Pharma
45 followers
NYU Langone Health
34 followers
West Pharmaceutical Services
10 followers
Curia Global
7 followers
AbbVie
295 followers
Navitus Health
6 followers
Xeris Pharmaceuticals
3 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
7 followers
Explore companies